AHR and breast carcinoma: In future studies, it will be interesting to compare the activity of analog E with that of Arzoxifene (LY 353381), which has been shown previously to prevent breast cancer in rat models [31], and is predicted to have similar AhR activation as raloxifene owing to the presence of the 6-hydroxyl group on the benzothiophene ring.